Published in Ann Hematol on May 14, 2010
Primary autoimmune thrombocytopenia and co-existing Graves' disease: Role of radioiodine-131. Indian J Nucl Med (2014) 0.78
Immunosuppressive treatment for immune thrombocytopenia which masked Graves' disease. J Family Med Prim Care (2015) 0.75
Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlap. Autops Case Rep (2015) 0.75
Relapsing thrombocytopenia leading to the diagnosis of pre-symptomatic Hashimoto's thyroiditis. Ann Hematol (2011) 0.75
Clinical practice. Graves' disease. N Engl J Med (2008) 5.78
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics. Acta Haematol (1980) 1.25
Thyroid disease in patients with immune thrombocytopenia. Hematol Oncol Clin North Am (2009) 1.24
Autoimmune thrombocytopenia (AITP) and thyroid autoimmune disease (TAD): overlapping syndromes? Clin Exp Immunol (1998) 1.18
Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indium-labeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab (1990) 1.13
Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am J Hematol (1992) 0.97
HLA matching in autoimmune thrombocytopenic purpura. Br J Haematol (1977) 0.89
Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology (2006) 3.29
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood (2012) 2.29
HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology (2004) 1.83
Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group. Am J Hematol (2012) 1.77
How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet (2011) 1.20
Extranodal natural-killer/t-cell lymphoma, nasal type. Adv Hematol (2010) 1.17
IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J Neuroinflammation (2010) 1.11
Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol (2013) 1.07
PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene (2004) 1.05
Molecular pathways in hepatocellular carcinoma. Cancer Lett (2005) 1.01
Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis. J Clin Microbiol (2004) 0.98
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients. Br J Haematol (2004) 0.96
Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab. Haematologica (2006) 0.93
PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin. Am J Pathol (2013) 0.91
Immune blood biomarkers of Alzheimer disease patients. J Neuroimmunol (2009) 0.90
A route to enantiopure RNA precursors from nearly racemic starting materials. Nat Chem (2011) 0.90
Regular virologic surveillance showed very frequent cytomegalovirus reactivation in patients treated with alemtuzumab. Am J Hematol (2007) 0.89
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. Hum Mutat (2012) 0.89
Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine. Ann Hematol (2012) 0.87
The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain. J Biol Chem (2013) 0.86
The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment. Dev Cell (2012) 0.85
Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression. Ann Hematol (2009) 0.84
A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML. Blood (2014) 0.83
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. J Transl Med (2014) 0.82
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD. J Hematol Oncol (2012) 0.82
Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results. Ann Hematol (2011) 0.81
MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. J Alzheimers Dis (2011) 0.81
Non-nasal natural killer cell lymphoma: not non-nasal after all. Ann Hematol (2008) 0.80
LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens. Eur J Haematol (2014) 0.80
Disseminated Infections with Talaromyces marneffei in Non-AIDS Patients Given Monoclonal Antibodies against CD20 and Kinase Inhibitors. Emerg Infect Dis (2015) 0.79
Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure. Ann Hematol (2014) 0.78
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment. Clin Transplant (2012) 0.78
Novel therapeutic agents for T-cell lymphomas. Discov Med (2013) 0.78
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor. Am J Hematol (2013) 0.78
Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis. Hematology (2015) 0.77
Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady. Chin Med J (Engl) (2012) 0.77
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Ann Hematol (2013) 0.77
Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delay. Hum Mutat (2013) 0.76
Cytomegalovirus retinitis complicating combination therapy with rituximab and fludarabine. Ann Hematol (2015) 0.76
Histiocytic sarcoma simulating immune thrombocytopenic purpura. Ann Hematol (2012) 0.75
T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression. Ann Hematol (2010) 0.75
Myeloid sarcoma of the uterine cervix presenting as missed abortion. Arch Gynecol Obstet (2012) 0.75
Persistent neutropenia in chronic myelogenous leukemia in chronic phase treated with imatinib mesylate. Am J Hematol (2009) 0.75
Uveitis as the initial manifestation of diffuse large B-cell lymphoma. Am J Hematol (2011) 0.75
Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma. Histopathology (2011) 0.75
Erratum: Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy. Am J Gastroenterol (2016) 0.75
Familial distal foregut atresia in a family with likely autosomal dominant inheritance pattern. Pediatr Surg Int (2012) 0.75
Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome. J Clin Pathol (2010) 0.75
Japanese Encephalitis Virus Transmitted Via Blood Transfusion, Hong Kong, China. Emerg Infect Dis (2018) 0.75
Protein-losing enteropathy due to T-cell large granular lymphocyte leukemia. J Clin Oncol (2009) 0.75
Bone marrow uptake of indolent non-Hodgkin lymphoma on PET/CT with histopathological correlation. Nucl Med Commun (2015) 0.75
Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion. Ann Hematol (2014) 0.75
Two tales of two lymphomas. J Clin Oncol (2011) 0.75